Growth Metrics

Emergent BioSolutions (EBS) Liabilities from Discontinued Operations (2023 - 2025)

Emergent BioSolutions has reported Liabilities from Discontinued Operations over the past 4 years, most recently at 4500000.0 for Q3 2025.

  • For Q3 2025, Liabilities from Discontinued Operations changed N/A year-over-year to 4500000.0; the TTM value through Sep 2025 reached 4500000.0, changed N/A, while the annual FY2015 figure was 17348000.0, N/A changed from the prior year.
  • Liabilities from Discontinued Operations for Q3 2025 was 4500000.0 at Emergent BioSolutions, down from 4700000.0 in the prior quarter.
  • Over five years, Liabilities from Discontinued Operations peaked at 37500000.0 in Q1 2023 and troughed at 4500000.0 in Q3 2025.
  • A 3-year average of 12320000.0 and a median of 4800000.0 in 2025 define the central range for Liabilities from Discontinued Operations.
  • On a YoY basis, Liabilities from Discontinued Operations climbed as much as 53.47% in 2025 and fell as far as 53.47% in 2025.
  • Year by year, Liabilities from Discontinued Operations stood at 37500000.0 in 2023, then tumbled by 73.07% to 10100000.0 in 2024, then plummeted by 55.45% to 4500000.0 in 2025.
  • Business Quant data shows Liabilities from Discontinued Operations for EBS at 4500000.0 in Q3 2025, 4700000.0 in Q2 2025, and 4800000.0 in Q1 2025.